companydata.dkLICA PHARMACEUTICALS ApS: Financial statements 2024
CVR: 25332520
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 210,297 and a net result of DKK 1,406,816 compared with DKK 1,731,068 the year before. That is a decrease of 10.2% compared with the year before. Equity amounted to DKK 23,770,576. The solvency ratio was 98.4%. The company had 1 employee in the financial year.
- Gross Profit
- 210,297 kr.
- Profit/Loss
- 1,406,816 kr.
- Equity
- 23,770,576 kr.
- Total Assets
- 24,158,031 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 210 t. | 1.4 mio. | 23.8 mio. | 1 |
| 2023 | - | 234 t. | 1.7 mio. | 22.4 mio. | 1 |
| 2022 | - | 313 t. | -1.5 mio. | 20.6 mio. | 1 |
| 2021 | - | 371 t. | 2.6 mio. | 22.2 mio. | 1 |
| 2020 | - | 326 t. | 844 t. | 19.6 mio. | 0 |
How creditworthy is LICA PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
LICA PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK 234,223, and the net result was DKK 1,731,068.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.